LumiThera, Inc.
Biotechnology company · Poulsbo, Washington, United States
LumiThera, Inc. is a biotechnology company headquartered in Poulsbo, Washington, United States. Its earliest recorded incorporation is in 2013. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $6.3 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $2 million sold in a notice filed in 2019.
LumiThera at a glance
What does LumiThera do?
US government research funding
5 SBIR/STTR small-business research awards from US health agencies, $6.3 million in total (2015 to 2023). NIH funding came from the National Eye Institute.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $2 million sold (2019).
A site under this name is registered with the FDA by Alcon Laboratories, Inc..
Frequently asked questions about LumiThera
Where is LumiThera headquartered?
LumiThera, Inc. is headquartered in Poulsbo, Washington, United States.
What does LumiThera do?
LumiThera, Inc. is a biotechnology company.
When was LumiThera founded?
The earliest incorporation on record for LumiThera, Inc. is in 2013, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.